Bacil Pharma Ltd (524516) Stock Price & News

524516:BOM

Bacil Pharma Ltd

₹21.41

-2.46%

(-0.54) 1D

Oct 16, 3:57:51 PM GMT+5:30 · INR

All symbols

	Symbol	Price	Change	% Change

Last report

Oct 14, 2026

Fiscal period

Q2 2027

- / -

Revenue / Est. (INR)

918.00K / -

Fiscal Q2 2027 earnings call

Waiting for the earnings call

At a glance

Insights from the latest news and reports

Previous reportsAll values in INR

Loading Previous Earnings...

All values in INR	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	-	-	-	918.00K
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	60.00K	109.00K	72.00K	72.00K
Operating expense	253.00K	743.00K	227.00K	593.00K
Total operating expenses	253.00K	743.00K	227.00K	593.00K
Operating income	-253.00K	-743.00K	-227.00K	325.00K
Other non operating income	645.00K	-1.22M	891.00K	-
EBT including unusual items	392.00K	390.00K	664.00K	-299.00K
EBT excluding unusual items	392.00K	390.00K	664.00K	-299.00K
Income tax expense	-	-7.95M	825.00K	423.00K
Effective tax rate	-	-2,037.95%	124.25%	-141.47%
Other operating expenses	193.00K	634.00K	155.00K	521.00K
Net income	392.00K	8.34M	-161.00K	-722.00K
Net profit margin	-	-	-	-78.65%
Earnings per share	-	-	-	-
Interest and investment income	-	2.35M	-	-
Interest expense	-	-	-	-624.00K
Net interest expenses	-	2.35M	-	-624.00K
Depreciation and amortization charges	-	-	-	-
EBITDA	-251.25K	-741.25K	-	-
Gain or loss from assets sale	-	-	-	-

Finance